I-Sofosbuvir CAS 1190307-88-0 Ubumsulwa ≥99.0% (HPLC)

Incazelo emfushane:

Igama: Sofosbuvir

I-CAS: 1190307-88-0

Ukubukeka: I-Crystalline Powder Emhlophe ukuya Kokumhlophe

Ubumsulwa: ≥99.0% (HPLC)

I-Sofosbuvir ekwelapheni i-Hepatitis C Virus (HCV)

Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso

Thintana: UDkt. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

I-Sofosbuvir Related Intermediate:

1190307-88-0 - Izakhiwo Zamakhemikhali:

Igama I-Sofosbuvir
Omqondofana GS-7977;I-PSI-7977
Inombolo ye-CAS 1190307-88-0
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu
I-Molecular Formula I-C22H29FN3O9P
Isisindo samangqamuzana 529.45
I-Melting Point 120.0~125.0℃
Ukuminyana 1.41
Ukuncibilika I-Soluble ku-DMF, DMSO, Ethanol
Isimo Sokuthumela Ngaphansi Kwezinga Lokushisa Le-Ambient
I-COA ne-MSDS Iyatholakala
Umsuka Shanghai, China
I-Shelf Life Izinyanga Ezingama-36 Uma Zigcinwe Ngokufanelekile
Ibhrendi I-Ruifu Chemical

1190307-88-0 - Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder emhlophe ukuya kokumhlophe
Ukuhlonza I-HPLC;I-RT
Ukuhlanzeka / Indlela Yokuhlaziya ≥99.0% (HPLC)
EE ≥99.0%
Ukulahlekelwa Ekumisweni ≤1.0%
Izinsalela ekushiseni ≤0.20%
Ukungcola Okukodwa ≤0.50%
Ukungcola Okuphelele ≤1.0%
Izinsimbi Ezisindayo ≤20ppm
Izincibilikisi Ezisele Hlangana nezidingo zokucaciswa
I-Methanol ≤1500ppm
I-TBME ≤2500ppm
I-Dichloromethane ≤720ppm
I-Tetrahydrofuran ≤720ppm
I-Toluene ≤60ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Sofosbuvir (CAS: 1190307-88-0) ekwelapheni i-Hepatitis C Virus (HCV)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Drum, noma ngokwezidingo zekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama

Izinzuzo:

1

I-FAQ:

www.ruifuchem.com

1190307-88-0 - Isicelo:

I-Sofosbuvir (CAS: 1190307-88-0) (ebhalwe ngokusemthethweni njenge-PSI-797, GS-7977) iyi-phosphoramidate prodrug kanye ne-nucleotide polymerase inhibitor yokwelapha ukutheleleka kwegciwane le-hepatitis C (HCV) elingamahlalakhona.Kunconywa ukuthi kusetshenziswe ngokuhambisana nezinye izidakamizwa (njenge-velpatasvir) ekwelashweni komugqa wokuqala kwe-HCV genotypes 1, 2, 3, 4, 5, kanye no-6. Kusebenza ngokusebenza njenge-nucleotide analog inhibitor, ekwazi ukuvimbela ngokukhethekile i-HCV NS5B (i-non-structural protein 5B) i-RNA polymerase encike ku-RNA.

Bhala umyalezo wakho lapha futhi usithumelele wona